Alfred Clinical Trials

Alfred Health has more than 700 open trials across 20 clinical disciplines, our clinical trial portfolio is one of the largest in the country.

Clear filter
604 clinical trials found
Clinical trials

DECIDE

DExmedetomidine in Cardiac surgical Intraoperative Drug Evaluation (ACTRN12623001171606)

Currently recruiting

DEFiNE GPS

Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting (short title: DEFiNE GPS) (NCT04451044)

Currently recruiting

Duavive in PMD

Double-Blind Randomised Investigation of Bazedoxifene and conjugated estrogen for Depression in Menopausal Women (ACTRN12620001015932)

Currently recruiting

DREAMM7

DREAMM7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared with the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants with Relapsed/Refractory Multiple Myeloma – DREAMM 7 (NCT04246047)

Currently recruiting

Epidyolex Study

Effect of cannabidiol on sleep in developmental and epileptic encephalopathies (ACTRN12623000855628p)

Currently recruiting

NOTACS

Effect of Nasal High-Flow Oxygen Therapy on Patient-Centred Outcomes in Patients at High Risk of Postoperative Pulmonary Complications After Cardiac Surgery: A Multicentre Randomised Controlled Trial (NCT05308719)

No longer recruiting

NN9500-4656

Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial (NCT05016882)

Currently recruiting

HB-PD-002

Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (NCT05071430)

Currently recruiting

Accelagen Panic Disorder Study

Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (NCT06483789)

Currently recruiting

NeoFOL-R

Efficacy of Neoadjuvant FOLFIRINOX in Resectable pancreatic cancer: An international multicenter Randomized, controlled trial (NeoFOL-R) (ACTRN12624000005550)

Currently recruiting

Feasibility of Telehealth Model of Care

Evaluating a telehealth exercise model of care for adults with CF: A feasibility randomised controlled trial (ACTRN12625000116426)

Currently recruiting

S-BAN

Evaluating the effectiveness of sodium butyrate for treatment of anorexia nervosa in individuals aged 16 and over - an open-label proof of concept study (ACTRN12624000368538p)

Currently recruiting

VISAD

Evaluating Vi-polysaccharide vaccine responses in specific antibody deficiency patients receiving immunoglobulin replacement (VISAD Study) (ACTRN12621001059853)

Recently completed/closed

TVCR

Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction in Isolated Severe Tricuspid Regurgitation (ACTRN12620000564954p)

Currently recruiting

Tioga

Evaluation of Safety and Feasibility of the Tioga TMVR System for Treatment of Mitral Regurgitation (NCT06038838)

Currently recruiting

HALFMOON

Evaluation of safety and performance of the Half Moon Transcatheter Mitral Valve Repair (TMVr) System in High Risk Patients with Severe Symptomatic Mitral Regurgitation. (ACTRN04343313)

Currently recruiting

RIBFIX_ADVANTAGE

Evaluation of the RibFix™ Advantage Rib Fixation System for Surgical Repair of Rib Fractures (Trial Not Registered)

Currently recruiting

Ladera

Evaluation of the Safety and Performance of the Ladera Medical Suture-Mediated Large Bore Closure [LBC] System - The Ladera LBC Feasibility Study (NCT06358157)

Currently recruiting

EXPAND TAVR II

Evolut™ EXPAND TAVR II Pivotal Trial (NCT05149755)

Currently recruiting

Exercise and vaccination

Exercise as an immunomodulatory intervention and adjuvant to vaccination in people with COPD: feasibility randomised controlled trial. (ACTRN12624000372583)

Currently recruiting
20 21 22 23 24